World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
52437
World Ranking
4203
National Ranking
229

Axel Benner publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Axel Benner sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 581 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Axel Benner D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Axel Benner sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Axel Benner is affiliated with the German Cancer Research Center in Germany and has contributed extensively to medical research, particularly in hematology, molecular biology, and oncology. Their publication record comprises 254 works in medicine and 83 publications in biochemistry, genetics, and molecular biology.

Their subfields of research include hematology with 93 publications, molecular biology with 60, oncology with 49, pulmonary and respiratory medicine with 32, and genetics with 28. The primary research topics that Axel Benner focuses on include:

  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Hematopoietic Stem Cell Transplantation

Axel Benner frequently publishes in prominent scientific journals. The most common publication venues are Blood with 33 publications, Leukemia with 12, HemaSphere with 5, Journal of Clinical Oncology with 4, and International Journal of Cancer also with 4.

Some of their recent papers include:

  • "Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data" (2020, Nature Protocols)
  • "The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution" (2020, Nature Communications)
  • "Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma" (2023, Journal of Clinical Oncology)
  • "Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial" (2020, Blood)
  • "Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria" (2020, Blood)

Frequent co-authors collaborating with Axel Benner include:

  • Hartmut Döhner
  • Hartmut Goldschmidt
  • Konstanze Döhner
  • Lars Bullinger
  • Hans Salwender

The scope of Axel Benner's research portfolio reflects a significant focus on leukemia and myeloma, incorporating molecular diagnostic techniques and treatment evaluation. Their contributions span across clinical oncology and biomedical research, supporting advancements in understanding cancer pathology and therapeutic strategies.

Best Publications

  • Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    Hartmut Döhner;Stephan Stilgenbauer;Axel Benner;Elke Leupolt

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

    Richard F. Schlenk;Konstanze Döhner;Jürgen Krauter;Stefan Fröhling

  • Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances

    Sabina Solinas-Toldo;Stefan Lampel;Stephan Stilgenbauer;Jeremy Nickolenko

  • Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

    Stefan Fröhling;Richard F. Schlenk;Jochen Breitruck;Axel Benner

  • p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.

    Hartmut Döhner;Konstanze Fischer;Martin Bentz;Katrin Hansen

  • p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia.

    Rüdiger Klaes;Axel Benner;Tibor Friedrich;Rüdiger Ridder

  • CEBPA Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations

    Stefan Fröhling;Richard F. Schlenk;Ina Stolze;Jörg Bihlmayr

  • 11q Deletions Identify a New Subset of B-Cell Chronic Lymphocytic Leukemia Characterized by Extensive Nodal Involvement and Inferior Prognosis

    Hartmut Döhner;Stephan Stilgenbauer;Michael R. James;Axel Benner

  • Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

    Hendrik Witt;Stephen C. Mack;Marina Ryzhova;Sebastian Bender;Sebastian Bender

  • Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

    Thorsten Zenz;Alexander Kröber;Katrin Scherer;Sonja Häbe

  • Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.

    Niels Halama;Niels Halama;Inka Zoernig;Anna Berthel;Christoph Kahlert

  • Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy

    Niels Halama;Sara Michel;Matthias Kloor;Inka Zoernig

  • Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup

    RF Schlenk;A Benner;J Krauter;T Buchner

  • Prognostic Significance of Partial Tandem Duplications of the MLL Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia Study Group Ulm

    Konstanze Döhner;Karen Tobis;Regina Ulrich;Stefan Fröhling

  • Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.

    Richard F Schlenk;Sabine Kayser;Lars Bullinger;Guido Kobbe

  • Suppression of antitumor T cell immunity by the oncometabolite ( R )-2-hydroxyglutarate

    Lukas Bunse;Stefan Pusch;Theresa Bunse;Felix Sahm

  • A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q and 16p

    Le, Couteur, A;TP Kelly;T Berney;HR McConachie

  • Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers

    Yvette Schwitalle;Matthias Kloor;Susanne Eiermann;Michael Linnebacher

  • Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs

    W. Sauerbrei;C. Meier-Hirmer;A. Benner;P. Royston

Frequent Co-Authors

Hartmut Döhner
Hartmut Döhner University of Ulm
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Peter Lichter
Peter Lichter German Cancer Research Center
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Anna Jauch
Anna Jauch Heidelberg University
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Konstanze Döhner
Konstanze Döhner University of Ulm
Stephan Stilgenbauer
Stephan Stilgenbauer University of Ulm
Andreas E. Kulozik
Andreas E. Kulozik Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in healthcare careers grows, online education offers flexible ways to advance in the medical field. For those considering alternatives to traditional pre-med or medical pathways, there are several accredited programs to explore.

Many students start with nursing school online, which provides a solid foundation in patient care and clinical skills. These programs are ideal if you want to enter the workforce quickly and start gaining experience.

Licensed RNs looking to further their credentials may consider affordable rn to bsn programs. These programs are designed for working professionals and can lead to greater job opportunities and higher earning potential.

For those interested in advanced practice roles or research, online phd nursing programs offer a pathway to leadership and academic positions within healthcare.

Additionally, career-changers or non-nurses can pivot into nursing with direct entry msn programs online, fast-tracking them to a master's credential in nursing.

These online degrees make healthcare education more accessible, helping students from diverse backgrounds build rewarding medical and nursing careers.

Best Scientists Citing Axel Benner

Trending Scientists

Recently Published Articles